Literature DB >> 6647748

Osteomalacia in patients with chronic renal failure before dialysis or transplantation.

F J Mora Palma, H A Ellis, D B Cook, J H Dewar, M K Ward, R Wilkinson, D N Kerr.   

Abstract

The case records of 327 patients who underwent bone biopsy in late or terminal renal failure, before any form of dialysis or transplantation, were examined for clues to the aetiology of renal osteomalacia and its manifestations. Fifty four per cent of the biopsies showed pure osteitis fibrosa, 34 per cent osteomalacia with osteitis fibrosa and 12 per cent showed neither abnormality. Osteomalacia was strongly associated with chronic pyelonephritis and obstructive uropathy as primary renal disease. In two matched groups of 100 each, and within the major primary diseases, it was associated with acidosis, hypocalcaemia and normophosphataemia (as opposed to hyperphosphataemia). There was no association with known length or uraemia and only a weak and inconsistent relationship with severity of uraemia. In the few patients studied, there was no relationship between osteomalacia and serum 25-hydroxycholecalciferol level. In contrast to the state of patients treated by haemodialysis, osteomalacia in this undialysed group was manifested by a higher level of serum alkaline phosphatase than pure osteitis fibrosa, serum iPTH did not differ between the groups, there was no predominance of symptoms in one group, other than proximal myopathy which had a weak association with osteomalacia, and Looser zones were more common than complete fractures. Our study shows that osteomalacia has different manifestations, and probably different causes, before and after the start of haemodialysis. These two stages of renal failure should be clearly distinguished in reports of renal bone disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6647748

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  11 in total

1.  Acute epidemic aluminium osteomalacia secondary to water supply contamination.

Authors:  A A O'Brien; D P Moore; J A Keogh
Journal:  Ir J Med Sci       Date:  1990-03       Impact factor: 1.568

2.  Correction of metabolic acidosis in hemodialysis: consequences on serum leptin and mineral metabolism.

Authors:  Alessandra M Bales; Rosa M A Moysés; Luciene M dos Reis; Fabiana G Graciolli; James Hung; Manuel Carlos Martins Castro; Rosilene M Elias
Journal:  Int Urol Nephrol       Date:  2014-09-25       Impact factor: 2.370

3.  Who gets renal bone disease before beginning dialysis?

Authors:  T Cundy; D J Hand; D O Oliver; C G Woods; F W Wright; J A Kanis
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26

Review 4.  Role of bone biopsy in stages 3 to 4 chronic kidney disease.

Authors:  Anca Gal-Moscovici; Stuart M Sprague
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

5.  Aluminium osteomalacia in chronic renal failure patients neither on dialysis nor taking aluminium containing phosphate binders.

Authors:  A A O'Brien; D P Moore; J A Keogh
Journal:  Ir J Med Sci       Date:  1990-03       Impact factor: 1.568

6.  The effect of metabolic acidosis on vitamin D metabolites and bone histology in uremic rats.

Authors:  Y L Chan; E Savdie; R S Mason; S Posen
Journal:  Calcif Tissue Int       Date:  1985-03       Impact factor: 4.333

Review 7.  CHRONIC RENAL FAILURE - PITFALLS IN DIAGNOSIS.

Authors:  P K Prasher; P P Varma
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 8.  Recent developments in aluminum toxicology.

Authors:  F S Monteagudo; M J Cassidy; P I Folb
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jan-Feb

9.  Low bone mineral density due to secondary hyperparathyroidism in the GlatmTg(CAG-A4GALT) mouse model of Fabry disease.

Authors:  Hiroki Maruyama; Atsumi Taguchi; Mariko Mikame; Hongmei Lu; Norihiro Tada; Muneaki Ishijima; Haruka Kaneko; Mariko Kawai; Sawako Goto; Akihiko Saito; Riuko Ohashi; Yuji Nishikawa; Satoshi Ishii
Journal:  FASEB Bioadv       Date:  2020-06-10

Review 10.  Rethinking Bone Disease in Kidney Disease.

Authors:  Matthew J Damasiewicz; Thomas L Nickolas
Journal:  JBMR Plus       Date:  2018-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.